MolecuLightDX Measurement Feature Clinical Validation

NCT06682923 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2024-11-12

No results posted yet for this study

Summary

This is a prospective, single-arm, paired clinical evaluation of the MolecuLightDX device in the measurement of surface wounds in patients.

Conditions

  • Wounds
  • Wound of Skin

Interventions

DEVICE

MolecuLight DX Imaging Device

The MolecuLight DX Imaging Device is a fluorescence imaging device intended to acquire images from wounds. This will not alter the participant's standard of care treatment.

Sponsors & Collaborators

  • MolecuLight Inc.

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-23
Primary Completion
2025-02-28
Completion
2025-02-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06682923 on ClinicalTrials.gov